Pinnacle Bancorp, Inc. Vertex Pharmaceuticals Inc Transaction History

Pinnacle Bancorp, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$273.83 - $305.53 $7,941 - $8,860	-29 Reduced 48.33%	31 $9,000
Q1 2022 Apr 14, 2022	SELL	$221.42 - $260.97 $42,955 - $50,628	-194 Reduced 76.38%	60 $16,000
Q2 2021 Jul 15, 2021	BUY	$187.49 - $221.1 $2,812 - $3,316	15 Added 6.28%	254 $51,000
Q1 2021 Apr 26, 2021	BUY	$207.02 - $241.31 $49,477 - $57,673	239 New	239 $51,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Pinnacle Bancorp, Inc., based on Form 13F filings with the SEC.

Stay updated on Pinnacle Bancorp, Inc. with notifications on news.